Source: Annual Congress 2013 –COPD diagnosis
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Makarova, S. Avdeev, A. Chuchalin (Moscow, Russian Federation). Hypoxemia as a risk factor for endothelial dysfunction in COPD patients. Eur Respir J 2013; 42: Suppl. 57, 1540

Member's Comments

No comment yet.

Related content which might interest you: Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 COPD, cognition and vascular inflammation: Interrelation Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease Year: 2013 Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Increased small intestinal permeability during severe acute exacerbations of COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 COPD patients with exertional desaturation have a higher risk of rapid lung function decline Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls Source: International Congress 2016 – Systemic biomarkers Year: 2016 Effect of statins on endothelial dysfunction in patients with chronic obstructive pulmonary disease and metabolic syndrome Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Hypogonadism as a factor influencing health condition in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Functional status in high and low risk patient with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD Year: 2013 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Serum levels of RAAS components in COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Smoking induced pulmonary vascular remodelling in patients with mild COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Dyspnea: A risk factor associated with malnutrition in hospitalized pulmonary patients Source: International Congress 2017 – Best abstracts in the management of chronic respiratory diseases Year: 2017 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008